Samuel Z Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Brigham and Women's Hospital
Clotblog with Dr Samuel GoldhaberView all posts »
Statins and diabetes: Reviewing JUPITER with Dr Paul RidkerAug 10, 2012 08:50 EDT
Following the publication of his recent Lancet paper, Dr Paul Ridker joins Dr Goldhaber to discuss how the JUPITER data add to the debate.
- Ridker PM et al. Cardiovascular benefits and diabetes risk of statin therapy in primary prevention: An analysis of the JUPITER trial. Lancet 2012; 380:565-571. Abstract.
- JUPITER analysis helps assuage fears about diabetes risk with statins
- Statins, diabetes, and the FDA
- Life and times of leading cardiologists with Rob Califf. Guest: Paul Ridker